Ashok and Rita Patel Institute of Integrated Study and Research

Ānand, India

Ashok and Rita Patel Institute of Integrated Study and Research

Ānand, India
SEARCH FILTERS
Time filter
Source Type

Raval J.P.,Ashok and Rita Patel Institute of Integrated Study and Research | Akhaja T.N.,Ashok and Rita Patel Institute of Integrated Study and Research | Jaspara D.M.,Ashok and Rita Patel Institute of Integrated Study and Research | Myangar K.N.,Ashok and Rita Patel Institute of Integrated Study and Research | Patel N.H.,EMCURE Pharmaceuticals United States INC
Journal of Saudi Chemical Society | Year: 2014

In the present investigation, a series of 2(4-pyridyl)-5[(aryl/heteroarylamino)-1-oxoethyl]thio-1,3,4-oxadiazole were synthesized using isonicotinohydrazide and substituted aryl/heteroaryl amines using pyridine as solvent. Newly synthesized compounds were tested for their in vitro anti-tubercular activity against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Among the synthesized compounds, compounds 2(4-pyridyl)-5((2-nitrophenylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5e), 2(4-pyridyl)-5((4-nitrophenylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5g) and 2(4-pyridyl)-5((2-pyrrolylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5k) produced highest efficacy and exhibited. >90% inhibition at a concentration of 0.0077, 0.0052 and 0.0089. μM, respectively. All the new compounds were pharmacologically evaluated for their in vitro Antimicrobial activity. © 2011.

Loading Ashok and Rita Patel Institute of Integrated Study and Research collaborators
Loading Ashok and Rita Patel Institute of Integrated Study and Research collaborators